glp-1 drugs and pancreatitis Enzyme Rise May Link GLP-1, Do GLP-1 drugs cause pancreatitis?
Description
Early open-label studies with relatively small sample sizes using GLP-1R agonists such as liraglutide (122, 123) and dulaglutide (124) show promising effects in reducing binge episodes and weight in BED, but further research is needed to confirm their benefits across diverse populations

Guardian Australia revealed last month that online ghost stores masquerading as Australian businesses had expanded into advertising weight-loss treatments and were impersonating real people to recommend their products
by Dr Alexandra Cristina Cowell Writer & Clinical Content Reviewer Registered with GPhC (No

The rising prevalence of these chronic conditions has led to an increased demand for effective treatments, including GLP-1 analogues, to control diabetes and weight
Side Effects and Medical Monitoring Common Side Effects to Expect When starting GLP-1 agonists, gastrointestinal issues are the most frequent side effects, especially in the early weeks or when increasing the dosage